$AQST Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aquestive Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aquestive Therapeutics, Inc.. Get notifications about new insider transactions in Aquestive Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.04 | 20,000 | 80,800 | 20,000 | ||
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Gift | G | 0.00 | 62,500 | 0 | 12,585 | 75.1 K to 12.6 K (-83.24 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Buy | J | 0.00 | 1,783,578 | 0 | 1,948,578 | 165 K to 1.9 M (+1,080.96 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Sell | J | 0.00 | 2,249,077 | 0 | 0 | 2.2 M to 0 (-100.00 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Sell | J | 0.00 | 40,404 | 0 | 47,051 | 87.5 K to 47.1 K (-46.20 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Sell | J | 0.00 | 97,598 | 0 | 2,657,943 | 2.8 M to 2.7 M (-3.54 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Sell | J | 0.00 | 564,160 | 0 | 3,468,747 | 4 M to 3.5 M (-13.99 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Sell | J | 0.00 | 524,675 | 0 | 1,688,639 | 2.2 M to 1.7 M (-23.71 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | Cochran John | Buy | J | 0.00 | 19,091 | 0 | 136,986 | 117.9 K to 137 K (+16.19 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | Cochran John | Buy | J | 0.00 | 11,544 | 0 | 117,895 | 106.4 K to 117.9 K (+10.85 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | Cochran John | Buy | J | 0.00 | 8,228 | 0 | 106,351 | 98.1 K to 106.4 K (+8.39 %) | |
Mar 16 2021 | AQST | Aquestive Therapeu ... | Cochran John | Buy | J | 0.00 | 23,038 | 0 | 98,123 | 75.1 K to 98.1 K (+30.68 %) | |
Mar 15 2021 | AQST | Aquestive Therapeu ... | Krop Julie | Option Exercise | A | 5.30 | 28,500 | 151,050 | 28,500 | ||
Mar 15 2021 | AQST | Aquestive Therapeu ... | TOTH A ERNEST JR | Interim CFO | Option Exercise | A | 5.30 | 2,500 | 13,250 | 2,500 | |
Mar 15 2021 | AQST | Aquestive Therapeu ... | Wood Theresa | SVP-HR and Org. Dev ... | Option Exercise | A | 5.30 | 27,000 | 143,100 | 27,000 | |
Mar 15 2021 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | A | 5.30 | 250,000 | 1,325,000 | 250,000 | |
Mar 15 2021 | AQST | Aquestive Therapeu ... | Marshall Ken W. | SVP, Chief Commerci ... | Option Exercise | A | 5.30 | 40,000 | 212,000 | 40,000 | |
Feb 10 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.75 | 23,460 | 158,355 | 837,000 | 860.5 K to 837 K (-2.73 %) |
Feb 10 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.75 | 11,540 | 77,895 | 860,460 | 872 K to 860.5 K (-1.32 %) |
Feb 09 2021 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 6.50 | 40,792 | 265,148 | 872,000 | 912.8 K to 872 K (-4.47 %) |
Jan 04 2021 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Jan 04 2021 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Gift | G | 0.00 | 1,000 | 0 | 637,149 | 638.1 K to 637.1 K (-0.16 %) |
Jan 04 2021 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Jan 04 2021 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Gift | G | 0.00 | 1,000 | 0 | 638,149 | 639.1 K to 638.1 K (-0.16 %) |
Aug 19 2020 | AQST | Aquestive Therapeu ... | Maxwell John T. | SVP-Chief Financial ... | Sell | S | 8.00 | 3,000 | 24,000 | 150,614 | 153.6 K to 150.6 K (-1.95 %) |
Jun 18 2020 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 18 2020 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 18 2020 | AQST | Aquestive Therapeu ... | Lurker Nancy | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 18 2020 | AQST | Aquestive Therapeu ... | COSTA SANTO J | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 18 2020 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 18 2020 | AQST | Aquestive Therapeu ... | Cochran John | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 0 | |
Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.87 | 4,132 | 20,123 | 912,553 | 916.7 K to 912.6 K (-0.45 %) |
Jun 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 916,685 | 902.1 K to 916.7 K (+1.62 %) |
Jun 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 0 | |
Jun 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 4.87 | 6,492 | 31,616 | 688,964 | 695.5 K to 689 K (-0.93 %) |
Jun 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 695,456 | 680.9 K to 695.5 K (+2.14 %) |
May 04 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 4.00 | 40,000 | 160,000 | 942,113 | 982.1 K to 942.1 K (-4.07 %) |
May 04 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 3.70 | 40,000 | 148,000 | 982,113 | 1 M to 982.1 K (-3.91 %) |
May 01 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Sell | S | 4.50 | 40,000 | 180,000 | 1,022,113 | 1.1 M to 1 M (-3.77 %) |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 333 | |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 2.19 | 99 | 217 | 680,884 | 681 K to 680.9 K (-0.01 %) |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 680,983 | 680.7 K to 681 K (+0.05 %) |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 333 | |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 2.19 | 97 | 212 | 1,062,113 | 1.1 M to 1.1 M (-0.01 %) |
Apr 02 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,062,210 | 1.1 M to 1.1 M (+0.03 %) |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Slatko Gary H | SVP, Chief Medical ... | Option Exercise | A | 1.54 | 50,000 | 77,000 | 50,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Wood Theresa | SVP-HR and Org. Dev ... | Option Exercise | A | 1.54 | 30,000 | 46,200 | 30,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 1.54 | 70,000 | 107,800 | 70,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Maxwell John T. | SVP-Chief Financial ... | Option Exercise | A | 1.54 | 60,000 | 92,400 | 60,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Marshall Ken W. | SVP, Chief Commerci ... | Option Exercise | A | 1.54 | 45,400 | 69,916 | 45,400 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Slatko Gary H | SVP, Chief Medical ... | Option Exercise | A | 1.54 | 50,000 | 77,000 | 50,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Wood Theresa | SVP-HR and Org. Dev ... | Option Exercise | A | 1.54 | 30,000 | 46,200 | 30,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | A | 1.54 | 70,000 | 107,800 | 70,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Maxwell John T. | SVP-Chief Financial ... | Option Exercise | A | 1.54 | 60,000 | 92,400 | 60,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Marshall Ken W. | SVP, Chief Commerci ... | Option Exercise | A | 1.54 | 45,400 | 69,916 | 45,400 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | A | 1.54 | 225,000 | 346,500 | 225,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Barber Daniel | SVP-Chief Operating ... | Option Exercise | A | 1.54 | 110,000 | 169,400 | 110,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | BRAENDER LORI J | SVP, General Counse ... | Option Exercise | A | 1.54 | 60,000 | 92,400 | 60,000 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | BRAENDER LORI J | SVP, General Counse ... | Buy | P | 1.54 | 14,000 | 21,624 | 25,000 | 11 K to 25 K (+127.27 %) |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Boyd Peter E. | SVP-Bus. Process & ... | Option Exercise | A | 1.54 | 50,700 | 78,078 | 50,700 | |
Mar 18 2020 | AQST | Aquestive Therapeu ... | Boyd Peter E. | SVP-Bus. Process & ... | Buy | P | 1.50 | 2,000 | 3,000 | 52,239 | 50.2 K to 52.2 K (+3.98 %) |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 14,572 | |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.73 | 5,066 | 18,896 | 1,061,881 | 1.1 M to 1.1 M (-0.47 %) |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,066,947 | 1.1 M to 1.1 M (+1.38 %) |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 14,572 | |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 3.73 | 4,729 | 17,639 | 680,654 | 685.4 K to 680.7 K (-0.69 %) |
Mar 03 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 685,383 | 670.8 K to 685.4 K (+2.17 %) |
Jan 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 662 | |
Jan 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 5.82 | 329 | 1,915 | 662,656 | 663 K to 662.7 K (-0.05 %) |
Jan 02 2020 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 662,985 | 662.7 K to 663 K (+0.05 %) |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 29,144 | |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 7.79 | 14,572 | 113,516 | 662,656 | 677.2 K to 662.7 K (-2.15 %) |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 677,228 | 662.7 K to 677.2 K (+2.20 %) |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 29,144 | |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 7.79 | 14,572 | 113,516 | 1,044,165 | 1.1 M to 1 M (-1.38 %) |
Dec 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,058,737 | 1 M to 1.1 M (+1.40 %) |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 991 | |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.18 | 145 | 461 | 1,044,165 | 1 M to 1 M (-0.01 %) |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,044,310 | 1 M to 1 M (+0.03 %) |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 991 | |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 3.18 | 150 | 477 | 662,656 | 662.8 K to 662.7 K (-0.02 %) |
Oct 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 662,806 | 662.5 K to 662.8 K (+0.05 %) |
Sep 20 2019 | AQST | Aquestive Therapeu ... | Marshall Ken W. | SVP, Chief Commerci ... | Option Exercise | A | 3.49 | 66,000 | 230,340 | 66,000 | |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 43,716 | |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 3.80 | 6,676 | 25,369 | 662,477 | 669.2 K to 662.5 K (-1.00 %) |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 669,153 | 654.6 K to 669.2 K (+2.23 %) |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 43,716 | |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.80 | 6,460 | 24,548 | 1,043,981 | 1.1 M to 1 M (-0.61 %) |
Sep 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,050,441 | 1 M to 1.1 M (+1.41 %) |
Aug 27 2019 | AQST | Aquestive Therapeu ... | Barber Daniel | SVP-Chief Operating ... | Buy | P | 3.99 | 2,000 | 7,980 | 101,959 | 100 K to 102 K (+2.00 %) |
Aug 27 2019 | AQST | Aquestive Therapeu ... | Barber Daniel | SVP-Chief Operating ... | Buy | P | 3.99 | 2,000 | 7,980 | 101,959 | 100 K to 102 K (+2.00 %) |
Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.81 | 900 | 3,429 | 31,635 | 30.7 K to 31.6 K (+2.93 %) | |
Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.80 | 11,310 | 43,001 | 30,735 | 19.4 K to 30.7 K (+58.22 %) | |
Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.77 | 10,761 | 40,547 | 19,425 | 8.7 K to 19.4 K (+124.20 %) | |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 3.65 | 1,000 | 3,650 | 654,581 | 653.6 K to 654.6 K (+0.15 %) |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 3.70 | 1,000 | 3,697 | 653,581 | 652.6 K to 653.6 K (+0.15 %) |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 4.05 | 1,000 | 4,045 | 652,581 | 651.6 K to 652.6 K (+0.15 %) |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 4.00 | 2,000 | 7,990 | 651,581 | 649.6 K to 651.6 K (+0.31 %) |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 3.93 | 1,000 | 3,925 | 649,581 | 648.6 K to 649.6 K (+0.15 %) |
Aug 20 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | P | 3.84 | 2,000 | 7,680 | 648,581 | 646.6 K to 648.6 K (+0.31 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 4.20 | 154 | 647 | 646,581 | 646.7 K to 646.6 K (-0.02 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 4.20 | 154 | 647 | 646,581 | 646.7 K to 646.6 K (-0.02 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 646,735 | 646.4 K to 646.7 K (+0.05 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 646,735 | 646.4 K to 646.7 K (+0.05 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,320 | |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.20 | 149 | 626 | 1,035,869 | 1 M to 1 M (-0.01 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 4.20 | 149 | 626 | 1,035,869 | 1 M to 1 M (-0.01 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,036,018 | 1 M to 1 M (+0.03 %) |
Jul 02 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,036,018 | 1 M to 1 M (+0.03 %) |
Jun 17 2019 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Lurker Nancy | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Cochran John | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | COSTA SANTO J | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Lurker Nancy | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Cochran John | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | COSTA SANTO J | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 17 2019 | AQST | Aquestive Therapeu ... | BRATTON DOUGLAS K | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 58,288 | |
Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 3.72 | 6,591 | 24,519 | 1,035,689 | 1 M to 1 M (-0.63 %) |
Jun 03 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,042,280 | 1 M to 1 M (+1.42 %) |
Jun 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 58,288 | |
Jun 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 3.72 | 6,780 | 25,222 | 646,406 | 653.2 K to 646.4 K (-1.04 %) |
Jun 03 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 653,186 | 638.6 K to 653.2 K (+2.28 %) |
May 10 2019 | AQST | Aquestive Therapeu ... | Barber Daniel | SVP-Chief Operating ... | Option Exercise | A | 4.83 | 50,000 | 241,500 | 50,000 | |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 329 | 0 | 1,649 | |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 6.91 | 263 | 1,817 | 1,027,708 | 1 M to 1 M (-0.03 %) |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 329 | 0 | 1,027,971 | 1 M to 1 M (+0.03 %) |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 329 | 0 | 1,649 | |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 6.91 | 263 | 1,817 | 638,614 | 638.9 K to 638.6 K (-0.04 %) |
Apr 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 329 | 0 | 638,877 | 638.5 K to 638.9 K (+0.05 %) |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | SVP,Chief Innov/Tec ... | Option Exercise | A | 8.05 | 75,000 | 603,750 | 75,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | BRAENDER LORI J | SVP, General Counse ... | Option Exercise | A | 8.05 | 100,000 | 805,000 | 100,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Barber Daniel | SVP-Chief Strategy/ ... | Option Exercise | A | 8.05 | 70,000 | 563,500 | 70,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Boyd Peter E. | SVP-Operations/Valu ... | Option Exercise | A | 8.05 | 30,000 | 241,500 | 30,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | A | 8.05 | 325,000 | 2,616,250 | 325,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Maxwell John T. | SVP-Chief Financial ... | Option Exercise | A | 8.05 | 95,000 | 764,750 | 95,000 | |
Mar 04 2019 | AQST | Aquestive Therapeu ... | Wood Theresa | SVP-HR and Org. Dev ... | Option Exercise | A | 8.05 | 45,000 | 362,250 | 45,000 | |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Option Exercise | M | 0.00 | 14,572 | 0 | 72,860 | |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Payment of Exercise | F | 8.05 | 4,725 | 38,036 | 638,548 | 643.3 K to 638.5 K (-0.73 %) |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Kendall Keith J | CEO and President | Buy | M | 0.00 | 14,572 | 0 | 643,273 | 628.7 K to 643.3 K (+2.32 %) |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Option Exercise | M | 0.00 | 14,572 | 0 | 72,860 | |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Payment of Exercise | F | 8.05 | 6,721 | 54,104 | 1,027,642 | 1 M to 1 M (-0.65 %) |
Mar 01 2019 | AQST | Aquestive Therapeu ... | Schobel Alexander Mark | Chief Innovation/Te ... | Buy | M | 0.00 | 14,572 | 0 | 1,034,363 | 1 M to 1 M (+1.43 %) |